Product: Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
Reason for recall: Failed Dissolution Specifications
Recall initiated: 20170207
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated